Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | NR2E1 | Q9Y466 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23621548 | 0.98 | ESR1 (0.31) | ESR1ESR2MEN1THRBRECQL | |
| SCHEMBL23614258 | 0.98 | ESR1 (0.31) | ESR1ESR2MEN1THRBRECQL | |
| SCHEMBL23614997 | 0.98 | ESR1 (0.33) | ESR1ESR2 | |
| SCHEMBL25451924 | 0.98 | ESR1 (0.33) | ESR1ESR2 | |
| SCHEMBL23614608 | 0.97 | HSD17B1 (0.31) | — | |
| SCHEMBL23614693 | 0.97 | ESR1 (0.32) | ESR1ESR2MEN1THRBRECQL | |
| SCHEMBL23621500 | 0.97 | ESR1 (0.32) | ESR1ESR2MEN1THRBRECQL | |
| SCHEMBL23621021 | 0.97 | ESR1 (0.32) | ESR1ESR2 | |
| SCHEMBL23621654 | 0.96 | HSD17B1 (0.32) | — | |
| SCHEMBL23614375 | 0.96 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11827615-B2 | Nitrogen-containing compound, electronic element and electronic device | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-11-28 | — | — | US | disclosed |
| US-11827615-B2 | Nitrogen-containing compound, electronic element and electronic device | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-11-28 | — | — | US | disclosed |
| US-20220081408-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC DEVICE | SHAANXI LTMS OPTOELECTRONICS MATERIAL CO. LTD. (CN) | 2022-03-17 | — | — | US | disclosed |
| US-11203584-B2 | Nitrogen-containing compound, electronic element and electronic device | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2021-12-21 | — | — | US | disclosed |
| US-20210206741-A1 | Nitrogen-containing compound, electronic element and electronic device | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2021-07-08 | — | — | US | disclosed |
| EP-3845522-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC DEVICE | Shaanxi Lighte Optoelectronics Material Co., Ltd. (CN) | 2021-07-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210206741-A1 | Nitrogen-containing compound, electronic element and electronic device | NOS1, PRMT1, MNS1 | ESR1 9/4885ESR2 57/4885MEN1 182/4885 |
| US-11827615-B2 | Nitrogen-containing compound, electronic element and electronic device | NOS1, PRMT1, MNS1 | ESR1 9/4885ESR2 57/4885MEN1 182/4885 |
| US-20220081408-A1 | NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC DEVICE | NOS1, PRMT1, MNS1 | ESR1 9/4885ESR2 57/4885MEN1 182/4885 |
| US-11203584-B2 | Nitrogen-containing compound, electronic element and electronic device | NOS1, PRMT1, MNS1 | ESR1 9/4885ESR2 57/4885MEN1 182/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.